FACCHINETTI, FIORELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.330
EU - Europa 2.236
AS - Asia 644
OC - Oceania 29
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.251
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.322
RU - Federazione Russa 1.122
IE - Irlanda 417
IT - Italia 232
SG - Singapore 222
SE - Svezia 211
PL - Polonia 198
HK - Hong Kong 184
CN - Cina 154
IN - India 57
AU - Australia 29
GB - Regno Unito 27
UA - Ucraina 13
CA - Canada 8
CI - Costa d'Avorio 8
ID - Indonesia 8
JO - Giordania 8
VN - Vietnam 8
DE - Germania 6
EU - Europa 4
FI - Finlandia 3
FR - Francia 3
NL - Olanda 2
BE - Belgio 1
CH - Svizzera 1
CY - Cipro 1
JP - Giappone 1
KR - Corea 1
Totale 9.251
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.625
Fairfield 730
Dublin 417
Ashburn 331
Woodbridge 326
Seattle 310
Houston 251
Wilmington 222
Cambridge 214
Lawrence 214
Altamura 213
Warsaw 198
Singapore 178
Princeton 108
Hong Kong 107
Chandler 101
Boston 98
Ann Arbor 86
Beijing 85
Mumbai 54
Moscow 35
San Diego 35
Melbourne 29
Medford 26
Hillsboro 20
Shanghai 18
Kent 17
Buffalo 16
Norwalk 16
Falls Church 12
London 12
Boardman 11
Yubileyny 11
Abidjan 8
Andover 8
Jakarta 8
Redmond 7
Toronto 7
Dong Ket 6
Guangzhou 5
Milan 4
Chennai 3
Hounslow 3
Laurel 3
Los Angeles 3
New Bedfont 3
Hangzhou 2
Helsinki 2
Leawood 2
New York 2
Padova 2
Phoenix 2
Amsterdam 1
Bagno a Ripoli 1
Bern 1
Bremen 1
Chengdu 1
Chicago 1
Donetsk 1
Düsseldorf 1
Falkenstein 1
Florence 1
Foshan 1
Fremont 1
Greenwich 1
Islington 1
Leuven 1
Montréal 1
Naaldwijk 1
Nanjing 1
Nicosia 1
Palermo 1
Prescot 1
Quanzhou 1
Redwood City 1
Rui'an 1
San Jose 1
San Mateo 1
Sannomaru 1
Seoul 1
Shenzhen 1
Trumbull 1
Williamstown 1
Xuzhou 1
Yiwu 1
Totale 7.239
Salva come PNG Salva come JPEG
Nome #
Transient Receptor Potential Ankyrin 1 Channel Localized to Non-Neuronal Airway Cells Promotes Non-Neurogenic Inflammation 265
Pharmacological characterization of a highly selective Rho kinase (ROCK) inhibitor and its therapeutic effects in experimental pulmonary hypertension 155
Beta-endorphin, beta-lipotropin and adrenocorticotropic hormone levels in cerebrospinal fluid, and brain damage in chronic alcoholics 129
Opioid plasma levels during labour 127
Betalipotropin and betaendorphin in physiological and surgical menopause 127
Correlations between plasma levels of opioid peptides and adrenal androgens in prepuberty and puberty 126
Adrenal steroid responses to naloxone in polycystic ovarian disease 123
Puerperal breast feeding does not stimulate circulating opioids in humans 120
Benefits and risks of different hormonal replacement therapies in post-menopausal women 119
Ritanserin, a serotonin-S2 receptor antagonist, does not prevent 5-hydroxytryptophan-induced beta-EP, beta-LPH and cortisol secretion. 118
Plasma opioid levels in post-traumatic chronic headache and trigeminal neuralgia: maintained response to acupuncture. 118
Plasma opioids in the newborn in relation to the mode of delivery 117
Serial cervical length measurements after the 1st episode of threatened preterm labor improve prediction of spontaneous delivery prior to 37 weeks' gestation 116
Central acth deficit in degenerative and vascular demetria 114
Beta-lipotropin is the major component of the plasma opioid response to surgical stress in humans 114
OESTRADIOL/PROGESTERONE IMBALANCE AND THE PREMENSTRUAL SYNDROME 112
Aging brain and dementias: Changes in central opioids 112
Circulating beta-endorphin levels at various stages of life: possible connections with migraine pathogenesis 111
Circulating opioids and plasma renin activity in insulin-dependent diabetics with renal haemodynamic alterations 109
Primary pulmonary arterial hypertension: Protocol to assess comprehensively in the rat the response to pharmacologic treatments 109
Met-enkephalin enhances follicle-stimulating hormone-dependent progesterone production from cultured granulosa cells 108
Central deficiency of beta-Endorphin in alcohol addicts 107
Different releasing effects of traditional manual acupuncture and electro-acupuncture on proopiocortin-related peptides 106
Pituitary proopiomelanocortin peptides in mental disorders 105
Short-term effects of ovariectomy: the opioid control of LH secretion in fertile climateric and postmenopausal women 103
CSF and plasma levels of pro-opiomelanocortin-related peptides in reversible ischaemic attacks and strokes 102
Reduced estriol and dehydroepiandrosterone sulphate plasma levels in methadone-addicted pregnant women 102
Neuroendocrine evaluation of central opiate activity in primary headache disorders 101
Hyperendorphinemia in obesity and relationships to affective state 99
SOMATOSTATIN AND OXYTOCIN INFUSION INHIBITS THE RISE OF PLASMA β‐ENDORPHIN, β‐LIPOTROPHIN AND CORTISOL INDUCED BY INSULIN HYPOGLYCAEMIA 99
Lack of clinical-EEG effects of naloxone injection on infantile spasms 98
Absent B-endorphin response to clonidine in obese children 98
Monocrotaline-induced pulmonary arterial hypertension: Time-course of injury and comparative evaluation of macitentan and Y-27632, a Rho kinase inhibitor 98
Plasma and CSF Endorphin Levels in Primary and Symptomatic Headaches 97
Plasma B-endorphin resistance to dexamethasone suppression in obese patients 96
Circadian variations of proopiocortin-related peptides in children with migraine 96
Plasma beta-endorphin and beta-lipotropin levels increase in well trained athletes after competition and non competitive exercise 95
Different patterns of central and peripheral βEP, βLPH and ACTH throughout life 95
Endorphin patterns within the headache spectrum disorders 94
Opioid control of LH secretion in humans: Menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine 93
Endogenous opioid peptides in uterine fluid 93
Progesterone and progestins modulate beta endorphin concentrations in the hypothalamus and in the pituitary of castrated female rats 91
Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids 90
Dissociation between CSF and plasma B-endorphin in major depressive disorders: evidence for a different regulation 90
Effectiveness of Progestogens as Maintenance Tocolysis and Urogenital Cultures: Secondary Analysis of the PROTECT Trial 90
Oestrous cycle-related LH responsiveness to naloxone: Effect of high oestrogen levels on the activity of opioid receptors 87
Effects of Org OD 14 on pituitary and peripheral β-endorphin in castrated rats and post-menopausal women 87
beta-Endorphin and met-enkephalin in peritoneal and ovarian follicular fluids of fertile and postmenopausal women 85
Dysregulation of plasma pro-opiomelanocortin-related peptides in neurotic depression 85
Effetto dello stress da freddo nel coniglio sulle concentrazioni ipotalamiche, ipofisarie e plasmatiche di beta lipotropina e beta endorfina 85
Estrogen changes as a critical factor in modulation of central opioid tonus: Possible correlations with post-menopausal migraine 84
Localization and expression of the three opioid systems. 83
Menopause, depression, and plasma opioids 83
Impaired beta-endorphin response to human corticotropin-releasing hormone in obese children 82
Abnormal beta-endorphin and beta-lipotropin responses to TRH and LRH administration in primary and secondary affective disorders 82
Impairment of adrenergic-induced proopiomelanocortin-related peptide release in heroin addicts 81
Circulating opioids during sexual maturation 81
Opioid plasma levels in primary affective disorders: Effect of desimipramine therapy 81
FSH secretory pattern and degree of concordance with LH in amenorrheic, fertile, and postmenopausal women 81
Evaluation of central opioid tonus in menstrual migraine 81
Serotoninergic and Dopaminergic Control of Beta-Endorphin Secretion in Obese Children and Adolescents 80
FENOMENI DI ADATTAMENTO NEONATALE: SECREZIONE DI βLIPOTROPINA (βLPH) E βENDORFINA (βEP) NELLA PRIMA SETTIMANA DI VITA 80
Plasma endorphins in Rett syndrome: preliminary data. 80
The BLOSSoM study: Burnout after perinatal LOSS in Midwifery. Results of a nation-wide investigation in Italy 79
Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study 79
Plasma β-endorphin, free fatty acids and blood lipid changes in type 2 (non-insulin dependent) diabetic patients 78
Opioid plasma levels and uterine contractions during labour 78
Opioid peptides of the pituitary and hypothalamus: Changes in pregnant and lactating rats 78
Effects of neuroleptic treatments on peripheral opioid secretion 77
Impaired circadian rhythmicity of β-lipotrophin, β-endorphin and ACTH in heroin addicts 77
Impairment of the opioidergic control of luteinizing hormone secretion in Turner's syndrome: lack of effect of gonadal steroid therapy. 77
Proopiomelanocortin-Related Peptides in Feto-Placental Structures throughout Pregnancy 77
Dexamethasone fails to suppress hyperendorphinaemia of obese children 76
Plasma β-endorphin levels in obese and non-obese patients with polycystic ovarian disease 76
Central and peripheral beta-endorphin response to transcutaneous electrical nerve stimulation 75
No gradient exists between lumbar and ventricular cerebrospinal fluid BETA-endorphin 75
Fetomaternal opioid levels and parturition 75
Acetyl-L-carnitine acutely administered raises β-endorphin and cortisol plasma levels in humans 75
Secretion pattern of endogenous opioids in chronic schizophrenia 75
N‐terminal ACTH fragments increase the CSF β‐EP content in Alzheimer type dementia 75
Plasma beta‐endorphin, cortisol and norepinephrine responses to physical and metabolic stressors in young and elderly humans 75
Involvement of serotonin in the central control of opioid secretion 75
Reduced ACTH, while normal β-endorphin CSF levels in early epileptic encephalopathies 74
PEPTIDI OPPIOIDI CIRCOLANTI NELL'INSUFFICIENZA RENALE CRONICA: EFFETTO ACUTO DEL TRATTAMENTO DIALITICO 74
Oestrus cycle-related LH responsiveness to naloxone: effect of high estrogen levels on the activity of opioid receptors 73
Ontogeny of pituitary beta-endorphin and related peptides in the human embryo and fetus 72
Plasma beta-endorphin in response to oral glucose tolerance test in obese patients 72
Central ACTH deficit in degenerative and vascular dementia. 72
Response of circulating adrenocorticotropin, beta-endorphin, beta-lipotropin and cortisol to athletic competition 68
Transient failure of central opioid tonus and premenstrual symptoms 63
Neuroendocrine events in postmenopausal women: Changes in hypothalamic-pituitary-adrenal and gonadal axis in basal conditions and during hot flushes 63
Effect of oral contraceptives or dexamethasone on plasma beta-endorphin during the menstrual cycle 62
OPPIOIDI E RIPRODUZIONE 61
Stress e analgesia postoperatoria 61
Impairment of opioid control of luteinizing hormone secretion in menstrual disorders 61
Propiocortin-related peptides in ageing 60
REPONSES HYPOPHYSAIRES ASPECIFIQUES DANS LE DIABETE INSULINODEPENDANT DES ENFANTS ET DES ADOLESCENTS 59
Opioid plasma levels: a marker of impaired central control in psychiatric disorders? 59
Plasma beta-endorphin levels in anovulatory states: Changes after treatments for the induction of ovulation 59
Effect of chlorimipramine and cyanoimipramine therapy Effect of chlorimipramine and cyanoimipramine therapy 58
Totale 9.098
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020909 0 0 0 0 0 0 204 207 202 129 129 38
2020/2021582 74 51 3 97 44 45 18 11 106 24 86 23
2021/2022657 19 68 70 34 16 27 35 46 25 26 70 221
2022/20231.385 167 448 45 23 37 244 237 37 102 4 31 10
2023/2024324 16 36 106 18 18 34 1 48 4 7 28 8
2024/20254.460 249 430 257 568 1.895 1.037 24 0 0 0 0 0
Totale 9.382